Riata Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 37.75 Cr
as on 16-12-2024
- Paid Up Capital ₹ 36.85 Cr
as on 16-12-2024
- Company Age 11 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 M
as on 16-12-2024
- Satisfied Charges ₹ 11.00 Cr
as on 16-12-2024
About Riata Life Sciences
The Corporate was formerly known as Riata Organics Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 37.75 Cr and a paid-up capital of Rs 36.85 Cr.
The company currently has active open charges totaling ₹5.00 M. The company has closed loans amounting to ₹11.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Manish Mittal, Krishnamohan Puvvada, and Sanjay Soor serve as directors at the Company.
- CIN/LLPIN
U15100MH2013PTC402612
- Company No.
073250
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jan 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Riata Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Mittal  | Director | 09-Dec-2021 | Current |
| Krishnamohan Puvvada | Director | 09-Dec-2021 | Current |
| Sanjay Soor | Director | 09-Dec-2021 | Current |
Financial Performance of Riata Life Sciences.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Riata Life Sciences?
Unlock access to Riata Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Uas Life Sciences India Private LimitedActive 10 years 9 monthsKrishnamohan Puvvada is a mutual person
Synergia Life Sciences Private LimitedActive 20 years 9 monthsManish Mittal, Krishnamohan Puvvada and 1 more are mutual person
Novozymes South Asia Private LimitedActive 26 years 4 monthsManish Mittal and Krishnamohan Puvvada are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 18 Oct 2019 | ₹5.00 M | Open |
Bank Of Baroda Creation Date: 20 Jun 2013 | ₹5.50 Cr | Satisfied |
Bank Of Baroda Creation Date: 10 Apr 2013 | ₹5.50 Cr | Satisfied |
How Many Employees Work at Riata Life Sciences?
Unlock and access historical data on people associated with Riata Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Riata Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Riata Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
